Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Hepregen Corp.
3123
Hepregen Corp.
Technology
Biotechnology
Hepregen's HepatoPac® and HepatoMune™ liver models are the most predictive in vitro tools on the market for assessing drug metabolism and potential hepatotoxici
Suggest edits
Founded
2007
Raised
$4M
Follow us
Companies in the same industry
QUIBIM S.L.
Sitka Biopharma
GEN1 Biotechnology
ViraCyte
Pherecydes Pharma
BridgeBio
Enlivex Therapeutics
LabGenius
Symphony Dynamo
Biophytis
Alexa global traffic share
Twitter followers
Overview
Funding
3
Add info
Add round
25 May
2011
$500,000
Grant
Massachusetts Life Sciences Center
15 Jan
2010
$500,000
Grant
Battelle Ventures
02 Sep
2008
$3,000,000
Venture capital (Series A)
Battelle Ventures
,
Innovation Valley Partners
